dihydroergotamine has been researched along with Brain Ischemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buonvicino, D; Chiarugi, A; De Cesaris, F; Muzzi, M | 1 |
| Czechanowski, B; Heinrich, F | 1 |
| Fukushima, T; Itakura, T; Matsuoka, Y; Ogawa, Y; Shintomi, K; Yoshimoto, K | 1 |
1 trial(s) available for dihydroergotamine and Brain Ischemia
| Article | Year |
|---|---|
[Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's transl)].
Topics: Aged; Brain Ischemia; Dihydroergotamine; Double-Blind Method; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Obesity; Placebos; Rest; Thrombophlebitis | 1981 |
2 other study(ies) available for dihydroergotamine and Brain Ischemia
| Article | Year |
|---|---|
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury.
Topics: Animals; Antihypertensive Agents; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Dihydroergotamine; Disease Models, Animal; Drug Evaluation, Preclinical; Dura Mater; Male; Mice, Inbred C57BL; Prazosin; Pyrrolidines; Random Allocation; Rats, Sprague-Dawley; RNA, Messenger; Serotonin Receptor Agonists; Time Factors; Tryptamines; Vasoconstrictor Agents | 2017 |
[Pharmacological study of nicergoline. (II). Protective effect on ischemic brain damages in animals].
Topics: Animals; Brain; Brain Ischemia; Dihydroergotamine; Energy Metabolism; Ergolines; Female; Gerbillinae; Lipid Peroxides; Male; Mice; Mice, Inbred ICR; Nicergoline; Rats; Rats, Inbred Strains; Seizures | 1986 |